ShedrX Review 2026: Tirzepatide Cost, Pricing, and How It Compares

Last Updated: March 2026

The landscape of weight loss medication continues its rapid evolution, with GLP-1 (glucagon-like peptide-1) receptor agonists like tirzepatide demonstrating profound efficacy. In the SURMOUNT-1 trial, tirzepatide led to a mean weight reduction of 22.5% at 72 weeks for participants on the 15 mg dose, compared to 2.4% for placebo (NEJM, 2022). Such significant results have spurred immense demand, yet the high cost of brand-name medications remains a substantial barrier for many. This has fueled the rise of telehealth platforms like ShedrX, offering more accessible — primarily compounded — versions of these potent drugs. This comprehensive review dives into ShedrX’s 2026 offerings, focusing on tirzepatide cost, included services, and how it measures up against competitors like Remedy Meds and Henry Meds.

The Rise of Telehealth GLP-1 Providers

The convenience of telehealth, combined with the groundbreaking effectiveness of GLP-1 medications, has created a new frontier in obesity management. Historically, access to these cutting-edge treatments was constrained by insurance coverage, specialized endocrinologist visits, and prohibitive out-of-pocket costs. Telehealth platforms promise to democratize access, streamlining the process from initial consultation to medication delivery.

However, this accessibility comes with its own set of considerations, particularly concerning the use of compounded medications. Compounding pharmacies prepare customized medications for individual patients, often due to specific medical needs, allergies, or in cases where a commercial drug is in shortage. For GLP-1s, compounding has become a workaround for the high list prices of brand-name drugs like Zepbound (tirzepatide) and Wegovy (semaglutide). While these compounded versions can drastically reduce costs, they are not FDA-approved, meaning they haven’t undergone the same rigorous safety and efficacy testing as their brand-name counterparts.

The FDA has explicitly warned against using compounded GLP-1 products. “Compounded drugs are not FDA-approved,” the agency states, “and have not undergone FDA’s rigorous premarket review for safety, effectiveness, and quality” (FDA, 2024). Despite these warnings, many patients turn to compounded options due to the extreme financial pressure posed by brand-name drug prices.

ShedrX Overview: A Telehealth Pathway to Weight Loss

ShedrX positions itself as a direct-to-consumer telehealth provider specializing in GLP-1 medications for weight management. Their model typically involves an online medical assessment, a telehealth consultation with a licensed provider, and subsequent home delivery of prescribed medication. ShedrX aims to offer a simplified, often more affordable, path to GLP-1 therapy compared to traditional in-person healthcare channels burdened by complex insurance procedures and high deductibles.

The company’s service package generally encompasses the medical consultation, prescription, and the medication itself, often with shipping included. They primarily dispense compounded versions of GLP-1s, enabling them to offer competitive pricing that significantly undercuts the list price of brand-name medications.

ShedrX Tirzepatide Pricing in 2026

In 2026, ShedrX offers compounded tirzepatide in a “drops” format (likely oral solution or sublingual drops) with a monthly cost ranging from $299 to $399. This pricing structure aims to make tirzepatide more accessible to a broader patient base.

This price range typically covers:

• Initial and follow-up telehealth consultations: Access to a licensed medical provider for assessment, prescription, and ongoing monitoring.
• Compounded tirzepatide medication: The specific dosage prescribed by the provider, dispensed from a partner compounding pharmacy.
• Shipping: Delivery of the medication directly to the patient’s home.

It is crucial for patients to understand that this cost is for compounded tirzepatide, not the brand-name Zepbound. The significant price difference is the primary driver for ShedrX’s model. For context, the list price of brand-name Zepbound can exceed $1,000 per month without insurance. While government deals announced in 2025 aimed to reduce prices for programs like Medicare and Medicaid to around $245 per month for certain GLP-1s, and some agreements projected an average price of $346 per month via specific programs, these reductions are not universally available, and the cash price remains high for many (AJMC, 2025; Pharmacy Times, 2025).

The cost-effectiveness of GLP-1s is a critical discussion point. A 2025 analysis in JAMA Health Forum modeled tirzepatide’s net price and found it would require a further 30.5% reduction from its modeled net price, down to approximately $4,334 per year (or ~$361 per month), to meet cost-effectiveness thresholds at the $100,000-per-QALY standard (JAMA Health Forum, 2025). ShedrX’s compounded tirzepatide pricing falls within this cost-effective range, highlighting its appeal.

Factors Influencing ShedrX’s Tirzepatide Cost:

• Dosage: Higher dosages may fall at the higher end of the stated price range.
• Program duration: Some providers offer discounts for multi-month subscriptions, though ShedrX typically advertises monthly pricing.
• Geographic location: State regulations regarding telehealth and compounded medications can impact availability and, in rare cases, pricing.
• Formulation: While ShedrX specifies “drops,” other compounded forms (e.g., injectable vials) might exist through other providers and carry different costs.

What’s Included with ShedrX Services?

Beyond the core medication and consultation, understanding the full scope of ShedrX’s offering is vital for prospective patients.

1. Telehealth Consultations:

   • Initial Assessment: Patients complete a detailed online health questionnaire. A licensed medical provider (physician, physician assistant, or nurse practitioner) reviews this information to determine eligibility. This includes discussing medical history, current health status, and weight loss goals.
   • Live Consultation: A video or phone call with the provider to discuss the treatment plan, potential side effects, and answer patient questions. This is where a prescription for compounded tirzepatide would be issued if appropriate.
   • Follow-ups: Regular check-ins, often via secure messaging or scheduled calls, to monitor progress, adjust dosages, and address any concerns. The frequency and depth of these follow-ups can vary.

2. Compounded Tirzepatide Medication:

   • Prescription: Issued by the ShedrX provider.
   • Dispensing: The prescription is sent to a partner compounding pharmacy (FDA-registered and state-licensed) which prepares and dispenses the medication.
   • Formulation: ShedrX specifically markets “drops,” implying an oral or sublingual delivery method, which can be appealing for those averse to injections.

3. Shipping:

   • Medication is typically shipped directly to the patient’s home in discreet packaging. Shipping costs are generally bundled into the monthly fee.

4. Support and Resources:

   • Patient Portal/Messaging: Most telehealth platforms offer a secure messaging system to communicate with the medical team for non-urgent questions.
   • Educational Materials: Access to information about GLP-1s, nutrition, and lifestyle changes may be provided, though the extent of dedicated coaching varies.

What May Not Be Included (or requires clarification):

• Lab Tests: Many GLP-1 programs recommend baseline and periodic lab tests (e.g., A1c, liver function, thyroid panel). It is essential to confirm whether ShedrX requires these, and if the cost of drawing and analyzing labs is covered or an out-of-pocket expense. Often, patients are responsible for arranging and paying for their lab work through a third-party facility.
• Intensive Lifestyle Coaching: While general guidance may be offered, dedicated 1:1 nutrition or fitness coaching is often an add-on service or not included in the basic package.
• Medication Administration Supplies: For injectable compounded tirzepatide (if offered, though ShedrX highlights drops), syringes and alcohol wipes would be necessary. Confirm if these are included. For drops, typically no additional supplies are needed.

ShedrX Physician Access and Support Quality

The quality of physician access and ongoing support is paramount for any telehealth weight loss program. With ShedrX, patients interact with licensed healthcare providers. The typical process involves:

• Provider Credentials: ShedrX, like other reputable telehealth services, employs licensed doctors, PAs, and NPs who are qualified to prescribe medications in the states where they operate.
• Accessibility: The primary advantage of telehealth is the ease of access. Consultations can be scheduled and conducted from home, eliminating travel time and waiting rooms. Communication often relies on asynchronous messaging for non-urgent inquiries.
• Continuity of Care: While patients may not always see the exact same provider for every interaction, the medical team should maintain comprehensive records to ensure consistent care.
• Response Times: For urgent medical concerns, telehealth platforms typically direct patients to emergency services. For program-related questions or side effect management, response times can vary. It’s important for patients to understand the expected communication channels and turnaround times.

The level of direct, personalized interaction might be less frequent than with a traditional in-person doctor who offers extensive one-on-one time. However, for many, the trade-off for convenience and affordability is acceptable, provided the medical oversight is sound.

Compounded vs. Brand-Name Tirzepatide: A Critical Distinction

The cost savings offered by ShedrX and similar platforms largely hinge on their use of compounded tirzepatide. Understanding the implications is crucial.

Brand-Name Tirzepatide (Zepbound):

• FDA-Approved: Zepbound has undergone rigorous clinical trials demonstrating its safety and efficacy for chronic weight management.
• Quality Control: Manufactured in FDA-inspected facilities under strict quality control standards.
• Consistent Formulation: Each dose contains a precise amount of the active ingredient, identical across batches.
• High Cost: List price typically exceeds $1,000 per month, often requiring robust insurance coverage or patient assistance programs.

Compounded Tirzepatide (e.g., from ShedrX):

• Not FDA-Approved: Has not undergone the same clinical trials or regulatory review for safety and efficacy as Zepbound.
• Variability: While legitimate compounding pharmacies adhere to certain standards, there can be more variability in the exact formulation, excipients, and stability compared to commercially manufactured drugs.
• Active Ingredient Source: Compounded versions often use tirzepatide salts (like tirzepatide acetate), which are structurally similar but not identical to the active pharmaceutical ingredient (API) in brand-name Zepbound. The FDA has raised concerns about the source and purity of these ingredients.
• Lower Cost: Significantly more affordable, making it accessible to a wider population.
• Legal Landscape: Compounding is legal under specific conditions, often when a drug is in shortage or to meet individual patient needs that cannot be met by an FDA-approved drug. However, the widespread compounding of GLP-1s due to high cost is a gray area that the FDA continues to monitor and warn against.

Patients considering compounded tirzepatide should be fully informed about these differences and discuss them thoroughly with their ShedrX provider.

Comparison Table: ShedrX vs. Remedy Meds vs. Henry Meds (Tirzepatide)

Comparing telehealth providers offering GLP-